Skip to content

Cost-effectiveness Analysis of a Sustainable Employability Intervention.

Cost-effectiveness Analysis of Sustainable Employability: A Dutch quasi experiment in Care for Companies/Second Care.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28297
Enrollment
140
Registered
2011-11-10
Start date
2011-11-20
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Work disability, physical and/or psychological complaints, sustainable employability, economic evaluation, cost-effectiveness

Interventions

The intervention starts with a multidisciplinary expertise. Hereby, spread over 1 or 2 days, depending on the needs of the patient, the physiotherapist (both surgery and training hall), occupational t
2. ‘Physical Journey’: The nature of the complaints and the insertion of the support / treatment is a very physical. A physical process broadly consists of a module physiotherapy, a rehabilitation mod

Sponsors

Stichting Instituut GAK (SIG) 's-Gravelandseweg 49 1217 EH HILVERSUM T 035 - 625 90 40 F 035 - 625 90 49 E info@instituutgak.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed with physical complaints; 2. Aged between 18 and 63; 3. Perform paid labor for at least 12 hours per week; 4. Ability to communicate in Dutch.

Exclusion criteria

Exclusion criteria: 1. Absenteeism for 1.5 years or longer; 2. Fulltime students with a student job; 3. Fulltime informal caregivers; 4. Fulltime volunteers.

Design outcomes

Primary

MeasureTime frame
1. A difference of 20% in the average no. of hours/days lost from work due to work disability between the intervention and the control group at 6, 12, and 18 months; 2. Cost per productivity lost reduction at 6, 12, and 18 months; 3. Cost per QALY at 6, 12, and 18 months.

Secondary

MeasureTime frame
1. Hours lost from work due to presenteeism; 2. Quality of life; 3. General health; 4. Costs and productivity losses; 5. Medical care consumption.

Contacts

Public ContactC.Y.G. Noben

P.O. Box 616 6200 MD

c.noben@maastrichtuniversity.nl+31 (0)43 3881834

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)